Jennifer Gartzke

Jennifer Gartzke serves as a primary procurement lead within the CDC Office of Acquisition Services, responsible for managing complex acquisitions that enable the agency’s mission to safeguard public health through advanced diagnostics, biomedical research, and laboratory capacity building. She oversees the full lifecycle of contract actions—from requirements definition and market research to award and performance monitoring—focusing on high-priority public health infrastructure needs. Her portfolio centers on mission-critical goods and services that support infectious disease surveillance, clinical testing, and rapid response operations, ensuring the CDC maintains operational readiness amid evolving health threats. Gartzke maintains strategic relationships with key contractors including General Dynamics Information Technology, GlaxoSmithKline, Cepheid, MRIGLOBAL, and New York City Health & Hospitals Corp., partnering with industry leaders in diagnostic technology, pharmaceutical supply, and biomedical research support. Her contracting approach emphasizes long-term vendor collaboration, performance-based outcomes, and compliance with federal acquisition regulations, particularly in areas requiring specialized technical expertise and regulatory oversight. She consistently engages with both large-scale prime contractors and niche suppliers capable of delivering high-complexity solutions under tight public health timelines. Her procurement patterns reflect a strong preference for open competition, with 87% of awards issued without set-aside designations, indicating a focus on broad market access and technical capability over socioeconomic categorization. Nevertheless, she actively supports small business participation, with 13% of awards allocated under Total Small Business Set-Asides, demonstrating a balanced commitment to both efficiency and socioeconomic goals within federal procurement frameworks. Gartzke’s technical focus is concentrated in NAICS 621511 (Medical Laboratories) and 424210 (Drugs and Druggists’ Sundries Merchant Wholesalers), reflecting her specialization in procuring clinical diagnostics, in-vitro diagnostic substances, and biomedical supply chains. Her expertise spans laboratory equipment, biosafety materials, and pharmaceutical logistics, positioning her at the intersection of public health science and federal acquisition policy.